Rare Diseases

The Offspring team represents a solid experience from research projects in the Pharmaceutical R&D industry, targeting rare disease. This includes work conducted in our current position as a CRO service provider supporting large pharmaceutical companies 
 
We operate by closely interacting with the team of disease experts and project team members at the client companies and we add to their research by bringing expertize founded on our skills to plan, execute and interpret histopahology-based analyses designed to target key questions for effective drug development 
 
This includes studies supporting target validation, biomarker development, profiling of drug binding properties, evaluations of effect and side effect risks as well supporting progression of the projects into clinical development  

Please contact our scientific team to discuss your rare disease project needs